publication . Report . 2016

Inmunodeficiencias y enfermedades autoinmunes: inmunodeficiencia común variable y Crohn-like

Saldaña-Dueñas, Cristina; Rubio-Iturria, Saioa;
Open Access English
  • Published: 01 Aug 2016
  • Publisher: Sociedad Española de Patología Digestiva
Abstract
Background: Common variable immunodeficiency (CVI) gives a major risk of principally respiratory and digestive infections. It is associated with autoimmune diseases, granulomatous process and neoplasias. The digestive clinic is common, in 10% of patients it is the only symptom, and 60% present chronic diarrhea. Clinically it can be confused and related with other pathologies such as inflammatory bowel disease which is infrequent (2-13%). Case report: We present the case of a patient with CVI with digestive symptoms being diagnosed of Crohn-like disease with extent ileal affectation. The main treatment of these patients is the same as classical Crohn disease alth...
Subjects
free text keywords: Common variable immunodeficiency, Inmunodeficiencia común variable, Inflammatory bowel disease, Anti-TNFα, Enfermedad inflamatoria intestinal
Related Organizations

1. Agarwal S, Smereka P, Harpaz N, et al. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis 2011;17:251-9. DOI: 10.1002/ibd.21376

2. Nos P, Bastida G, Beltran B, et al. Crohn's disease in common variable immunodeficiency: Treatment with antitumor necrosis factor alpha. Am J Gastroenterol 2006;101:2165-6. DOI: 10.1111/j.1572-0241. 2006.00763_5.x

3. Khodadad A, Aghamohammadi A, Parvaneh N, et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci 2007;52:2977-83. DOI: 10.1007/s10620-006-9736-6

4. Trigo-Salado C, Leo-Carnerero E, Pizarro-Moreno A, et al. Treatment with immunosupressants in a patient with Crohn's disease and common variable immunodeficiency. Gastroenterol Hepatol 2015;38:544-5. DOI: 10.1016/j.gastrohep.2014.09.008

5. Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol 2013;11:1050-63. DOI: 10.1016/j.cgh.2013.02.024

6. Daniels JA, Lederman HM, Maitra A, et al. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID). A clinicopathologic study and review 2007;31:1800-12. DOI: 10.1097/PAS.0b013e3180cab60c

7. Vázquez-Morón JM, Pallarés-Manrique H, Martín-Suárez IJ, et al. Enfermedad de Crohn-like en un paciente con inmunodeficiencia común variable tratada con azatioprina y adalimumab. Rev Esp Enferm Dig 2013;105:299-302. [OpenAIRE]

8. Sarmiento E, Mora R, Carbone J. Enfermedad autoinmune en inmunodeficiencias primarias de anticuerpos. Allergol et Immunopathol 2005;33:69-73. DOI: 10.1157/13072916

9. Chua I, Standish R, Lear S, et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodecfiiency (CVID). Clin Exp Immunol 2007;150:306-11. DOI: 10.1111/j.1365-2249.2007.03481.x [OpenAIRE]

Abstract
Background: Common variable immunodeficiency (CVI) gives a major risk of principally respiratory and digestive infections. It is associated with autoimmune diseases, granulomatous process and neoplasias. The digestive clinic is common, in 10% of patients it is the only symptom, and 60% present chronic diarrhea. Clinically it can be confused and related with other pathologies such as inflammatory bowel disease which is infrequent (2-13%). Case report: We present the case of a patient with CVI with digestive symptoms being diagnosed of Crohn-like disease with extent ileal affectation. The main treatment of these patients is the same as classical Crohn disease alth...
Subjects
free text keywords: Common variable immunodeficiency, Inmunodeficiencia común variable, Inflammatory bowel disease, Anti-TNFα, Enfermedad inflamatoria intestinal
Related Organizations

1. Agarwal S, Smereka P, Harpaz N, et al. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis 2011;17:251-9. DOI: 10.1002/ibd.21376

2. Nos P, Bastida G, Beltran B, et al. Crohn's disease in common variable immunodeficiency: Treatment with antitumor necrosis factor alpha. Am J Gastroenterol 2006;101:2165-6. DOI: 10.1111/j.1572-0241. 2006.00763_5.x

3. Khodadad A, Aghamohammadi A, Parvaneh N, et al. Gastrointestinal manifestations in patients with common variable immunodeficiency. Dig Dis Sci 2007;52:2977-83. DOI: 10.1007/s10620-006-9736-6

4. Trigo-Salado C, Leo-Carnerero E, Pizarro-Moreno A, et al. Treatment with immunosupressants in a patient with Crohn's disease and common variable immunodeficiency. Gastroenterol Hepatol 2015;38:544-5. DOI: 10.1016/j.gastrohep.2014.09.008

5. Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol 2013;11:1050-63. DOI: 10.1016/j.cgh.2013.02.024

6. Daniels JA, Lederman HM, Maitra A, et al. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID). A clinicopathologic study and review 2007;31:1800-12. DOI: 10.1097/PAS.0b013e3180cab60c

7. Vázquez-Morón JM, Pallarés-Manrique H, Martín-Suárez IJ, et al. Enfermedad de Crohn-like en un paciente con inmunodeficiencia común variable tratada con azatioprina y adalimumab. Rev Esp Enferm Dig 2013;105:299-302. [OpenAIRE]

8. Sarmiento E, Mora R, Carbone J. Enfermedad autoinmune en inmunodeficiencias primarias de anticuerpos. Allergol et Immunopathol 2005;33:69-73. DOI: 10.1157/13072916

9. Chua I, Standish R, Lear S, et al. Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodecfiiency (CVID). Clin Exp Immunol 2007;150:306-11. DOI: 10.1111/j.1365-2249.2007.03481.x [OpenAIRE]

Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue